CN101015599A - Composite Chinese medicine for treating pollen hypersensitivity symptom - Google Patents
Composite Chinese medicine for treating pollen hypersensitivity symptom Download PDFInfo
- Publication number
- CN101015599A CN101015599A CN 200710034466 CN200710034466A CN101015599A CN 101015599 A CN101015599 A CN 101015599A CN 200710034466 CN200710034466 CN 200710034466 CN 200710034466 A CN200710034466 A CN 200710034466A CN 101015599 A CN101015599 A CN 101015599A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- grams
- pollen hypersensitivity
- medicine composition
- radix
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal composition for treating pollen hypersensitivity which mainly comprises the following components (by weight portion): astragalus root 1-3 part, pilose asiabell root 1-3 parts, root of Dahurain angelica 0.3-1 part, silver flower 0.3-1 part, mulberry leaf 0.3-1 parts. The composition can be used for improving humen immunocompetence and enhancing ability to fight diseases.
Description
Technical field
The invention belongs to Chinese medicine composition, be specifically related to a kind of Chinese medicine composition for the treatment of pollen hypersensitivity.
Background technology
Pollen hypersensitivity is meant respiratory tract and the irritated performance of eye that is caused by pollen hypersensitivity, also is a kind of anaphylaxis of specificity individuality to pollen, medically is called " nasal sinusitis " or " allergic rhinitis ".There is the diagnosis of what is called " pyretic cold " morning among the people in China, means in spring and summer season, and in the time of the weather sweltering heat, the symptom of respiratory tract may appear suddenly in patient, and this is early stage observation and the description of China to pollen hypersensitivity.At present, it is about 5%~10% that global pollen hypersensitivity prevalence has reached, and the patient of China is also increasing year by year.The symptom of pollen hypersensitivity is sneeze, rhinorrhea, drops tears, and itches in nose, eye and external ear Dodge, and severe patient also can bring out tracheitis, bronchial asthma, pulmonary heart disease (multiple in summer and autumn).According to statistics, China urbanite sickness rate is about 0.9%, and popular district can reach about 5%.
For pollen hypersensitivity, the ideal medicine of inefficacy still both at home and abroad at present.Aspect Chinese medicine,, all be the method for taking the kidney invigorating cold relieving mainly with the prescribed treatment pollen hypersensitivity.Though these class methods are effective in cure, easily recurrence.Because the medicine of the kidney invigorating and cold relieving helps male sexuality, cause sexual life too much, will cause insufficiency of kidney-YANG like this, deficiency of kidney-QI causes human righteousness's weakness easily, and is just effective in cure at period in a medicine, and recurrence again can not tackle the problem at its root after the drug withdrawal.
Summary of the invention
The objective of the invention is provides a kind of good effect at above-mentioned situation, is difficult for the Chinese medicine composition of the treatment pollen hypersensitivity of recurrence.
The Chinese medicine composition of treatment pollen hypersensitivity of the present invention mainly is made up of the component of following weight portion:
Radix Astragali 1-3 part, Radix Codonopsis 1-3 part, Radix Angelicae Dahuricae 0.3-1 part, Flos Lonicerae 0.3-1 part, Folium Mori 0.3-1 part.
Be preferably: 2 parts of the Radixs Astragali, 2 parts of Radix Codonopsis, 0.5 part of the Radix Angelicae Dahuricae, 0.5 part of Flos Lonicerae, 0.5 part on Folium Mori.
The present invention can also increase the Rhizoma Atractylodis Macrocephalae, Cortex Magnoliae Officinalis, Flos Chrysanthemi Indici to improve therapeutic effect on the basis of said components, its weight portion is:
Rhizoma Atractylodis Macrocephalae 0.5-1.5 part, Cortex Magnoliae Officinalis 0.5-1 part, Flos Chrysanthemi Indici 0.3-1 part
Be preferably: 1 part of the Rhizoma Atractylodis Macrocephalae, 0.7 part of Cortex Magnoliae Officinalis, 0.5 part of Flos Chrysanthemi Indici.
The effect of each component in this compositions: Radix Codonopsis nature and flavor, sweet flat, invigorating the spleen and replenishing QI; Radix Astragali nature and flavor, Gan Wen, tonifying Qi and lifting yang, strengthening superficial resistance to stop perspiration, toxin expelling evacuation of pus, diuretic detumescent; Rhizoma Atractylodis Macrocephalae nature and flavor, hardship, Gan Wen, invigorating the spleen and replenishing QI, dampness diuretic, strengthening superficial resistance to stop perspiration; The Folium Mori nature and flavor, sweetness and bitterness, cold, wind and heat dispersing, liver heat removing and eyesight improving; The Flos Lonicerae nature and flavor, sweet cold, heat-clearing and toxic substances removing; The Flos Chrysanthemi Indici nature and flavor, sweetness and bitterness, cold, heat-clearing and toxic substances removing; The Cortex Magnoliae Officinalis nature and flavor, toil temperature, removing dampness intestinal stasis relieving, circulation of qi promoting are relievingd asthma: Radix Angelicae Dahuricae nature and flavor, Xin Wen, deliver dispel the wind, clearing the nasal passage, reducing swelling and alleviating pain.
The inventor thinks through studying for a long period of time that according to theory of Chinese medical science " institute of heresy plays, and its gas must be empty " " healthy energy internal memory, heresy can not be done " pollen hypersensitivity is the positive deficiency of vital energy of the person, and susceptible ailment said due to cold or exposure institute extremely.So, should take to set upright gas, the heat of dispeling the wind just can be received excellent curative.Chinese medicine of the present invention is developed with regard to being based on this theory.
Preparation technology
The component of said ratio is pulverized → is mixed → add entry soak in right amount (2-3 hour) fry in shallow oil 2 hours → filter back → simmer down to extractum → oven dry → addings adjuvant → for smalls → compacting in flakes → bottle of packing into → seal → put the cool place drying to locate preservation.
Chinese medicine composition of the present invention is to adopt the pure natural plant medicine, ophthalmic pruritus, rhinocnesmus, runny nose or nasal obstruction, the sneeze that pollen hypersensitivity (allergic rhinitis) is caused, sheds tears very then eyelid swelled hyperemia, diseases such as chemosis.Chronic rhinitis, sinusitis, institute are caused diseases such as turbid nasal discharge, nasal obstruction also to have good curative effect.
Its major function and effect: benefiting vital QI and blood, expelling wind and dampness, clear the nasal passage, wind and heat dispersing detoxifcation.
This Chinese medicine composition can improve the human body self immunocompetence, increases resistance against diseases, prevention and treatment pollen hypersensitivity (allergic rhinitis) and the chronic rhinitis that causes, sinusitis and various symptom.This medication is imitated significantly, instant effect, short treating period (7-15 days), and taking convenience does not have any toxicity, takes the back disease and is difficult for recurrence.
The specific embodiment:
Embodiment 1
Get the Radix Astragali 30 grams, Radix Codonopsis 25 grams, the Radix Angelicae Dahuricae 8 grams, Flos Lonicerae 8 grams, Folium Mori 8 grams.
Embodiment 2
Get the Radix Astragali 20 grams, Radix Codonopsis 20 grams, the Radix Angelicae Dahuricae 5 grams, Flos Lonicerae 5 grams, Folium Mori 5 grams.
Embodiment 3
Get the Radix Astragali 25 grams, Radix Codonopsis 25 grams, the Radix Angelicae Dahuricae 4 grams, 4 parts of Flos Lonicerae, 4 parts on Folium Mori, the Rhizoma Atractylodis Macrocephalae 13 grams, Cortex Magnoliae Officinalis 10 grams, Flos Chrysanthemi Indici 8 grams.
Embodiment 4
Get the Radix Astragali 20 grams, Radix Codonopsis 20 grams, the Radix Angelicae Dahuricae 5 grams, Flos Lonicerae 5 grams, Folium Mori 5 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, Cortex Magnoliae Officinalis 7 grams, Flos Chrysanthemi Indici 5 grams.
The component of each embodiment is made 0.5 tablet that restrains, oral three times of per day for adults, each three to five by aforementioned preparation technology respectively, the child is cut down according to the circumstance, obeying seven to 15 is a course of treatment, and pollen hypersensitivity is promptly had significant curative effect, obeys continuously and can consolidate no longer recurrence two courses of treatment.
Claims (4)
1, a kind of Chinese medicine composition for the treatment of pollen hypersensitivity is characterized in that mainly being made up of the component of following weight portion:
Radix Astragali 1-3 part, Radix Codonopsis 1-3 part, Radix Angelicae Dahuricae 0.3-1 part, Flos Lonicerae 0.3-1 part, Folium Mori 0.3-1 part.
2, Chinese medicine composition according to claim 1 is characterized in that each component adopts following weight portion:
2 parts of the Radixs Astragali, 2 parts of Radix Codonopsis, 0.5 part of the Radix Angelicae Dahuricae, 0.5 part of Flos Lonicerae, 0.5 part on Folium Mori.
3, Chinese medicine composition according to claim 1 is characterized in that also comprising in the component:
Rhizoma Atractylodis Macrocephalae 0.5-1.5 part, Cortex Magnoliae Officinalis 0.5-1 part, Flos Chrysanthemi Indici 0.3-1 part
4, Chinese medicine composition according to claim 3 is characterized in that each component adopts following weight portion:
1 part of the Rhizoma Atractylodis Macrocephalae, 0.7 part of Cortex Magnoliae Officinalis, 0.5 part of Flos Chrysanthemi Indici.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710034466 CN101015599A (en) | 2007-02-16 | 2007-02-16 | Composite Chinese medicine for treating pollen hypersensitivity symptom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200710034466 CN101015599A (en) | 2007-02-16 | 2007-02-16 | Composite Chinese medicine for treating pollen hypersensitivity symptom |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101015599A true CN101015599A (en) | 2007-08-15 |
Family
ID=38724926
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200710034466 Pending CN101015599A (en) | 2007-02-16 | 2007-02-16 | Composite Chinese medicine for treating pollen hypersensitivity symptom |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101015599A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890079A (en) * | 2010-04-29 | 2010-11-24 | 贵阳春科药业技术研发有限公司 | Medical preparation for preventing and treating rhinitis and preparation method thereof |
CN102920859A (en) * | 2012-11-19 | 2013-02-13 | 高扬 | Medicine for preventing pouen allergy |
CN103028037A (en) * | 2012-12-18 | 2013-04-10 | 张玉辉 | Traditional Chinese medicine prescription for treating allergic rhinitis |
CN103127383A (en) * | 2013-02-21 | 2013-06-05 | 冯玉芳 | Traditional Chinese medicine for treating children allergic rhinitis |
CN103655878A (en) * | 2012-09-11 | 2014-03-26 | 陈云玺 | Medicine for curing acute and chronic nasosinusitis through anapnotherapy |
CN111346206A (en) * | 2020-03-17 | 2020-06-30 | 朱晓明 | Perilla frutescens, ginger and ginseng tea and preparation method thereof |
-
2007
- 2007-02-16 CN CN 200710034466 patent/CN101015599A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101890079A (en) * | 2010-04-29 | 2010-11-24 | 贵阳春科药业技术研发有限公司 | Medical preparation for preventing and treating rhinitis and preparation method thereof |
CN101890079B (en) * | 2010-04-29 | 2014-08-06 | 贵阳春科药业技术研发有限公司 | Medical preparation for preventing and treating rhinitis and preparation method thereof |
CN103655878A (en) * | 2012-09-11 | 2014-03-26 | 陈云玺 | Medicine for curing acute and chronic nasosinusitis through anapnotherapy |
CN102920859A (en) * | 2012-11-19 | 2013-02-13 | 高扬 | Medicine for preventing pouen allergy |
CN102920859B (en) * | 2012-11-19 | 2014-02-19 | 高扬 | Medicine for preventing pollen allergy |
CN103028037A (en) * | 2012-12-18 | 2013-04-10 | 张玉辉 | Traditional Chinese medicine prescription for treating allergic rhinitis |
CN103127383A (en) * | 2013-02-21 | 2013-06-05 | 冯玉芳 | Traditional Chinese medicine for treating children allergic rhinitis |
CN111346206A (en) * | 2020-03-17 | 2020-06-30 | 朱晓明 | Perilla frutescens, ginger and ginseng tea and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103463609B (en) | The preparation method of the Chinese herbal oral decoction Chinese patent drug of the treatment infection of the upper respiratory tract | |
CN100355451C (en) | Cold-treating influenza-preventing medicine | |
CN103920106A (en) | Traditional Chinese medicinal composition for treating bronchitis and bronchial asthma | |
CN101015599A (en) | Composite Chinese medicine for treating pollen hypersensitivity symptom | |
CN104069474A (en) | Traditional Chinese medicine composition for treating seborrheic alopecia and preparation method thereof | |
CN101703686B (en) | Chinese medicinal composition for treating diabetes | |
CN103071047B (en) | Decoction for treating silicosis and preparation method thereof | |
CN102988649B (en) | Medicament for treating chronic bronchitis and preparation method of medicament | |
CN103656276B (en) | Medicine for the treatment of renal failure and preparation method thereof | |
CN104225339A (en) | Chinese medicinal preparation for treating chronic pneumonia and preparation method | |
CN104524058A (en) | Traditional Chinese medicine preparation for treating cerebral concussion and preparation method | |
WO2021103777A1 (en) | Spraying agent for preventing and treating allergic asthma combined with allergic rhinitis in children and teenagers | |
CN105853562A (en) | Pharmaceutical preparation for treating asthma and preparing method | |
CN103638513A (en) | Pectoral syrup for tonifying spleen and nourishing stomach | |
CN103405671A (en) | Traditional Chinese medicine for treating glaucoma caused by hyperactivity of liver-yang | |
CN1267143C (en) | Method for preparing compound medicinal capsule and powder for nourishing yin | |
CN1305727A (en) | Mixed ginseng tea | |
CN102430074B (en) | Traditional Chinese medicine composite for treating chronic bronchitis | |
CN106266771A (en) | A kind of Chinese medicine composition treating senile osteoporosis and preparation method thereof | |
CN104095124A (en) | Herbal tea and preparation method thereof | |
CN104413196A (en) | Enteromorpha anti-inflammation tea and preparation method thereof | |
CN104435853A (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
CN108114027A (en) | A kind of new medicine composition for treating allergic rhinitis and preparation method | |
CN105194279A (en) | Drug for treating dry eye syndrome | |
CN102178913B (en) | Skin care pill for treating cold sensitive disease and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Open date: 20070815 |